{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:28:23Z","timestamp":1790364503227,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hebei Medical Science Research Program","award":["20130345"],"award-info":[{"award-number":["20130345"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.neulet.2016.05.018","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T19:08:41Z","timestamp":1462993721000},"page":"19-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Conversion from MCI to AD in patients with the APOE \u03b54 genotype: Prediction by plasma HCY and serum BDNF"],"prefix":"10.1016","volume":"626","author":[{"given":"Lei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neulet.2016.05.018_bib0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol."},{"issue":"3","key":"10.1016\/j.neulet.2016.05.018_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"issue":"23","key":"10.1016\/j.neulet.2016.05.018_bib0015","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.neulet.2016.05.018_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresrev.2009.05.003","article-title":"Plasma biomarkers for mild cognitive impairment and Alzheimer's disease","volume":"61","author":"Song","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.neulet.2016.05.018_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jamda.2006.07.002","article-title":"A multi-center blinded prospective study of urine neural thread protein measurements in patients with suspected Alzheimer's disease","volume":"8","author":"Goodman","year":"2007","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"1-2","key":"10.1016\/j.neulet.2016.05.018_bib0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2011.03.023","article-title":"Increased plasma levels of lipocalin 2 in mild cognitive impairment","volume":"305","author":"Choi","year":"2011","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.neulet.2016.05.018_bib0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","article-title":"Identifying and validating biomarkers for Alzheimer's disease","volume":"29","author":"Humpel","year":"2011","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.neulet.2016.05.018_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000335729","article-title":"Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer\u2019s disease","volume":"33","author":"Ringman","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"7","key":"10.1016\/j.neulet.2016.05.018_bib0045","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","article-title":"Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives","volume":"9","author":"Hampel","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12 Suppl. (3)","key":"10.1016\/j.neulet.2016.05.018_bib0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1212\/WNL.64.12_suppl_3.S34","article-title":"Diagnosis and treatment of Alzheimer's disease","volume":"64","author":"Desai","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neulet.2016.05.018_bib0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/1354750X.2014.994036","article-title":"Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer's disease in patients with the apolipoprotein E \u03b54 genotype","volume":"20","author":"Wang","year":"2015","journal-title":"Biomarkers"},{"issue":"7","key":"10.1016\/j.neulet.2016.05.018_bib0060","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.pnpbp.2005.06.026","article-title":"Homocysteine and brain atrophy","volume":"29","author":"Sachdev","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neulet.2016.05.018_bib0065","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/gps.1716","article-title":"The rate of conversion of mild cognitive impairment to dementia: predictive role of depression","volume":"22","author":"Gabryelewicz","year":"2007","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.neulet.2016.05.018_bib0070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ajcn\/82.3.627","article-title":"High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study","volume":"82","author":"Tucker","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.neulet.2016.05.018_bib0075","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jpsychires.2006.01.014","article-title":"BDNF serum and CSF concentrations in Alzheimer's disease: normal pressure hydrocephalus and healthy controls","volume":"41","author":"Laske","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"10","key":"10.1016\/j.neulet.2016.05.018_bib0080","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.tins.2004.08.001","article-title":"BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders","volume":"27","author":"Mattson","year":"2004","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.neulet.2016.05.018_bib0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-150172","article-title":"Decreased neurotrophic support is associated with cognitive decline in non-Demented subjects","volume":"46","author":"Forlenza","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neulet.2016.05.018_bib0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.neulet.2016.05.018_bib0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"issue":"7","key":"10.1016\/j.neulet.2016.05.018_bib0100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neulet.2016.05.018_bib0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.neulet.2016.05.018_bib0110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixson","year":"1990","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.neulet.2016.05.018_bib0115","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/clinchem\/39.9.1764","article-title":"Total homocysteine in plasma or serum: methods and clinical applications","volume":"39","author":"Ueland","year":"1993","journal-title":"Clin. Chem."},{"issue":"1\u20132","key":"10.1016\/j.neulet.2016.05.018_bib0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0165-5728(02)00309-0","article-title":"CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker of Alzheimer's disease","volume":"132","author":"Tan","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.neulet.2016.05.018_bib0125","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.neulet.2016.05.018_bib0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000144072","article-title":"The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology","volume":"26","author":"Ramakers","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"9020","key":"10.1016\/j.neulet.2016.05.018_bib0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0140-6736(96)01251-2","article-title":"Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease","volume":"348","author":"Saunders","year":"1996","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.neulet.2016.05.018_bib0140","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(03)00438-1","article-title":"Homocysteine and Alzheimer's disease","volume":"2","author":"Morris","year":"2003","journal-title":"Lancet Neurol."},{"issue":"Pt 1","key":"10.1016\/j.neulet.2016.05.018_bib0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awg006","article-title":"Homocysteine and brain atrophy on MRI of non-demented elderly","volume":"126","author":"den Heijer","year":"2003","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.neulet.2016.05.018_bib0150","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasm a homocysteine as a risk factor for dementia and Alzheimer's disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.neulet.2016.05.018_bib0155","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/01.STR.27.12.2230","article-title":"Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly","volume":"27","author":"Kalmijn","year":"1996","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.neulet.2016.05.018_bib0160","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ana.21953","article-title":"Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease","volume":"67","author":"Vemuri","year":"2010","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.neulet.2016.05.018_bib0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JAD-2012-120973","article-title":"Lymphocytes from young healthy persons carrying the ApoE4 allele overexpress stress-related proteins involved in the pathophysiology of Alzheimer's disease","volume":"33","author":"Badia","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neulet.2016.05.018_bib0170","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3233\/JAD-140849","article-title":"Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease","volume":"42","author":"Alvarez","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neulet.2016.05.018_sbref0175a","doi-asserted-by":"crossref","first-page":"e35217","DOI":"10.1371\/journal.pone.0035217","article-title":"Plasma BDNF is associated with age-related white matter atrophy but not with cognitive function in older, non-demented adults","volume":"7","author":"Driscoll","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neulet.2016.05.018_sbref0175b","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0169-328X(95)00250-V","article-title":"Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF","volume":"36","author":"Poduslo","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"3","key":"10.1016\/j.neulet.2016.05.018_bib0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3940(02)00529-3","article-title":"Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets","volume":"328","author":"Karege","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2016.05.018_bib0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpsychires.2013.11.004","article-title":"Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study","volume":"49","author":"Diniz","year":"2014","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.neulet.2016.05.018_bib0190","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3109\/15622971003797241","article-title":"Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment","volume":"11","author":"Forlenza","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.neulet.2016.05.018_bib0195","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.61.8.1290","article-title":"Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study","volume":"61","author":"Modrego","year":"2004","journal-title":"Arch. Neurol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016303172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016303172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T09:49:07Z","timestamp":1718531347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394016303172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":40,"alternative-id":["S0304394016303172"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2016.05.018","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conversion from MCI to AD in patients with the APOE \u03b54 genotype: Prediction by plasma HCY and serum BDNF","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2016.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}